US equities
|
TSLA
$393.56
▲+5.73%
MU
$908.54
▲+3.53%
SPCX
$148.99
▲+1.02%
NVDA
$215.59
▲+2.19%
META
$640.44
▼-0.34%
SNDK
$1,267.44
▲+2.38%
AAPL
$344.55
▼-0.91%
INTC
$90.77
▲+4.38%
TSLA
$393.56
▲+5.73%
MU
$908.54
▲+3.53%
SPCX
$148.99
▲+1.02%
NVDA
$215.59
▲+2.19%
META
$640.44
▼-0.34%
SNDK
$1,267.44
▲+2.38%
AAPL
$344.55
▼-0.91%
INTC
$90.77
▲+4.38%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about CDMRP
Recent news which mentions CDMRP
OrPro Therapeutics Receives $2.147M Therapeutic Development Funding from US Department of Defense for COVID-19 and Influenza
July 19, 2022
Tags
Health
Icahn School of Medicine
United States
From
PRLog